NCT04829786View on ClinicalTrials.gov

Study to Compare the Pharmacokinetics, Safety, and Tolerability Following Administration of Palovarotene in Healthy Japanese and Non-Asian Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

October 23, 2015

Study Completion Date

October 23, 2015

Conditions
FOP
Interventions
DRUG

palovarotene low-dose

oral capsules

DRUG

palovarotene high-dose

oral capsules

Sponsors
All Listed Sponsors
lead

Clementia Pharmaceuticals Inc.

INDUSTRY